{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T05:09:22Z","timestamp":1695791362612},"reference-count":28,"publisher":"Wiley","issue":"s68","license":[{"start":{"date-parts":[[2007,8,23]],"date-time":"2007-08-23T00:00:00Z","timestamp":1187827200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1111\/j.1600-0609.2007.00941.x","type":"journal-article","created":{"date-parts":[[2007,8,23]],"date-time":"2007-08-23T12:34:13Z","timestamp":1187872453000},"page":"27-31","source":"Crossref","is-referenced-by-count":5,"title":["Essential thrombocythaemia treatment options: addressing patient\u2010specific needs"],"prefix":"10.1111","volume":"79","author":[{"given":"Gunnar","family":"Birgeg\u00e5rd","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,8,23]]},"reference":[{"key":"e_1_2_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2004.06.032"},{"key":"e_1_2_3_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19910515)67:10<2658::AID-CNCR2820671042>3.0.CO;2-C"},{"key":"e_1_2_3_4_2","doi-asserted-by":"publisher","DOI":"10.4065\/76.1.22"},{"key":"e_1_2_3_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8652(199905)61:1<10::AID-AJH3>3.0.CO;2-I"},{"key":"e_1_2_3_6_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002770050555"},{"key":"e_1_2_3_7_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0609.2000.90236.x"},{"key":"e_1_2_3_8_2","doi-asserted-by":"publisher","DOI":"10.4065\/81.2.159"},{"key":"e_1_2_3_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2005.01.001"},{"key":"e_1_2_3_10_2","doi-asserted-by":"publisher","DOI":"10.1053\/sonc.2002.33756"},{"key":"e_1_2_3_11_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1990.8.3.556"},{"key":"e_1_2_3_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19880315)61:6<1207::AID-CNCR2820610625>3.0.CO;2-4"},{"key":"e_1_2_3_13_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199504273321704"},{"key":"e_1_2_3_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043800"},{"key":"e_1_2_3_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.patbio.2004.02.007"},{"key":"e_1_2_3_16_2","first-page":"215","article-title":"Practice guidelines for the therapy of essential thrombocythemia. A statement from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation","volume":"89","author":"Barbui T","year":"2004","journal-title":"Haematologica"},{"key":"e_1_2_3_17_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2006-942758"},{"key":"e_1_2_3_18_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2006-942754"},{"key":"e_1_2_3_19_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2000.02188.x"},{"key":"e_1_2_3_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21797"},{"key":"e_1_2_3_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1994.tb01303.x"},{"key":"e_1_2_3_22_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V91.2.616"},{"key":"e_1_2_3_23_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428199609074368"},{"key":"e_1_2_3_24_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-09-3426"},{"key":"e_1_2_3_25_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.7.2297"},{"key":"e_1_2_3_26_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199712253372602"},{"key":"e_1_2_3_27_2","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1182\/blood.V90.9.3370","article-title":"Treatment of polycythemia vera: the use of hydroxyurea and pipobroman in 292 patients under the age of 65\u2003years","volume":"90","author":"Najean Y","year":"1997","journal-title":"Blood"},{"key":"e_1_2_3_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404473"},{"key":"e_1_2_3_29_2","first-page":"520","article-title":"Adverse effects and benefits of two years of anagrelide treatment for thrombocythemia in chronic myeloproliferative disorders","volume":"89","author":"Birgegard G","year":"2004","journal-title":"Haematologica"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0609.2007.00941.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0609.2007.00941.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T15:47:43Z","timestamp":1694620063000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0609.2007.00941.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,23]]},"references-count":28,"journal-issue":{"issue":"s68","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["10.1111\/j.1600-0609.2007.00941.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0609.2007.00941.x","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8,23]]}}}